Kaynes Tech Appoints Muthukumar Narayanaswamy as MD

Kaynes Technology has announced the appointment of Muthukumar Narayanaswamy as its new Managing Director for a 5-year term, effective September 24, 2025. This leadership change has positively influenced investor sentiment, lifting the company’s stock price.

Muthukumar Narayanaswamy Steps In as Managing Director

On September 24, 2025, Kaynes Technology informed exchanges that Muthukumar Narayanaswamy has been appointed as the new Managing Director for the next 5 years. He takes over from Ramesh Kunhikannan, who has been re-designated as the Executive Vice Chairman under the whole-time director category. The strategic reshuffle comes at a time when the firm continues to expand its manufacturing capabilities and technological footprint.

CEO Rajesh Sharma to Step Down by October End

Alongside the MD change, Kaynes Tech will also witness the exit of its current CEO, Rajesh Sharma. As stated in a regulatory filing, Sharma will officially step down on October 31, 2025, to pursue other career opportunities. His resignation was part of a planned process and has been in discussion for some time, as shared by CFO Jairam Sampath.

Internal Promotion for the CEO Role Expected Soon

The company is set to announce a successor for Sharma within 3 to 4 days. According to the management, the incoming CEO will be an internal candidate who has been with Kaynes Tech for the past year. This ensures business continuity and alignment with the ongoing projects and strategy execution.

Read More: Kaynes Technology CEO Rajesh Sharma Resigns Effective October 31, 2025!

Conclusion

Kaynes Technology has taken significant steps to strengthen its leadership with the appointment of Muthukumar Narayanaswamy as MD and planning for a smooth CEO transition. The market’s positive response reflects confidence in the company’s strategic direction and growth momentum.

Disclaimer:This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.